Mesalamine Tablet, Delayed Release
Product Images NDC 70771-1071

1 FDA label image from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70771-1071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mesalamine Dr Tablets, 1.2 G (Fbca41b2 19be 4a61 96d9 D75fb72d8474 01)

Mesalamine Dr Tablets, 1.2 G (Fbca41b2 19be 4a61 96d9 D75fb72d8474 01)
Label for Mesalamine Delayed-release Tablets 1.2 g by Zydus Lifesciences Limited. The label indicates a dosage form of delayed-release oral tablets, with a package size of 120 tablets, labeled Rx only. Storage instructions and dispensing guidance are also shown, along with the product NDC 70771-1071-1 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.